OBJECTIVES: This study was designed to investigate whether single nucleotide polymorphisms (SNPs) and haplotypes of the fibrinogen gene-cluster (fibrinogen chains alpha [FGA], beta [FGB], and gamma [FGG]) could explain the inter- and intraindividual variability of fibrinogen levels in patients with atherosclerosis. We also searched for genetic determinants affecting the responses of fibrinogen genes to proinflammatory stimulation. BACKGROUND: The mechanisms regulating fibrinogen levels are not fully understood, and they are likely to be regulated by complex gene-environment interactions. METHODS: In the AIRGENE study, 895 survivors of myocardial infarction from 5 European cities were followed prospectively for 6 to 8 months, and plasma fibrinogen, interleukin (IL)-6, and C-reactive protein levels were determined monthly. We analyzed 21 SNPs and the corresponding haplotypes in the 3 fibrinogen genes. RESULTS: Eight SNPs in FGA and FGB were significantly associated with fibrinogen levels. Similarly, 2 different haplotypes in FGA and 3 in FGB were also associated with mean fibrinogen levels. The IL-6 levels had a significant impact on the associations between SNPs/haplotypes in FGA/FGB and fibrinogen levels. We also identified SNPs and haplotypes in FGA and FGB with strong impact on the intraindividual variability of fibrinogen during the follow-up period. CONCLUSIONS: We identified common SNPs and haplotypes on FGA/FGB genes, explaining the interindividual and intraindividual variability of fibrinogen levels, in patients with a history of myocardial infarction. We have also identified for the first time, SNPs/haplotypes on FGA/FGB whose effects on fibrinogen expression are modified by the underlying IL-6 levels. These findings may have an impact on risk stratification and the design of genetically guided therapeutic approaches in patients with advanced atherosclerosis.
OBJECTIVES: This study was designed to investigate whether single nucleotide polymorphisms (SNPs) and haplotypes of the fibrinogen gene-cluster (fibrinogen chains alpha [FGA], beta [FGB], and gamma [FGG]) could explain the inter- and intraindividual variability of fibrinogen levels in patients with atherosclerosis. We also searched for genetic determinants affecting the responses of fibrinogen genes to proinflammatory stimulation. BACKGROUND: The mechanisms regulating fibrinogen levels are not fully understood, and they are likely to be regulated by complex gene-environment interactions. METHODS: In the AIRGENE study, 895 survivors of myocardial infarction from 5 European cities were followed prospectively for 6 to 8 months, and plasma fibrinogen, interleukin (IL)-6, and C-reactive protein levels were determined monthly. We analyzed 21 SNPs and the corresponding haplotypes in the 3 fibrinogen genes. RESULTS: Eight SNPs in FGA and FGB were significantly associated with fibrinogen levels. Similarly, 2 different haplotypes in FGA and 3 in FGB were also associated with mean fibrinogen levels. The IL-6 levels had a significant impact on the associations between SNPs/haplotypes in FGA/FGB and fibrinogen levels. We also identified SNPs and haplotypes in FGA and FGB with strong impact on the intraindividual variability of fibrinogen during the follow-up period. CONCLUSIONS: We identified common SNPs and haplotypes on FGA/FGB genes, explaining the interindividual and intraindividual variability of fibrinogen levels, in patients with a history of myocardial infarction. We have also identified for the first time, SNPs/haplotypes on FGA/FGB whose effects on fibrinogen expression are modified by the underlying IL-6 levels. These findings may have an impact on risk stratification and the design of genetically guided therapeutic approaches in patients with advanced atherosclerosis.
Authors: Petter Ljungman; Tom Bellander; Alexandra Schneider; Susanne Breitner; Francesco Forastiere; Regina Hampel; Thomas Illig; Bénédicte Jacquemin; Klea Katsouyanni; Stephanie von Klot; Wolfgang Koenig; Timo Lanki; Fredrik Nyberg; Juha Pekkanen; Riccardo Pistelli; Christos Pitsavos; Mårten Rosenqvist; Jordi Sunyer; Annette Peters Journal: Environ Health Perspect Date: 2009-04-06 Impact factor: 9.031
Authors: Eirini V Theodoraki; Tiit Nikopensius; Julia Suhorutsenko; Vassileios Peppes; Panagiota Fili; Genovefa Kolovou; Vassileios Papamikos; Dimitrios Richter; Nikolaos Zakopoulos; Kaarel Krjutskov; Andres Metspalu; George V Dedoussis Journal: BMC Med Genet Date: 2010-02-18 Impact factor: 2.103
Authors: Jens Baumert; Jie Huang; Barbara McKnight; Maria Sabater-Lleal; Maristella Steri; Audrey Y Chu; Stella Trompet; Lorna M Lopez; Myriam Fornage; Alexander Teumer; Weihong Tang; Alicja R Rudnicka; Anders Mälarstig; Jouke-Jan Hottenga; Maryam Kavousi; Jari Lahti; Toshiko Tanaka; Caroline Hayward; Jennifer E Huffman; Pierre-Emmanuel Morange; Lynda M Rose; Saonli Basu; Ann Rumley; David J Stott; Brendan M Buckley; Anton J M de Craen; Serena Sanna; Marco Masala; Reiner Biffar; Georg Homuth; Angela Silveira; Bengt Sennblad; Anuj Goel; Hugh Watkins; Martina Müller-Nurasyid; Regina Rückerl; Kent Taylor; Ming-Huei Chen; Eco J C de Geus; Albert Hofman; Jacqueline C M Witteman; Moniek P M de Maat; Aarno Palotie; Gail Davies; David S Siscovick; Ivana Kolcic; Sarah H Wild; Jaejoon Song; Wendy L McArdle; Ian Ford; Naveed Sattar; David Schlessinger; Anne Grotevendt; Maria Grazia Franzosi; Thomas Illig; Melanie Waldenberger; Thomas Lumley; Geoffrey H Tofler; Gonneke Willemsen; André G Uitterlinden; Fernando Rivadeneira; Katri Räikkönen; Daniel I Chasman; Aaron R Folsom; Gordon D Lowe; Rudi G J Westendorp; P Eline Slagboom; Francesco Cucca; Henri Wallaschofski; Rona J Strawbridge; Udo Seedorf; Wolfgang Koenig; Joshua C Bis; Kenneth J Mukamal; Jenny van Dongen; Elisabeth Widen; Oscar H Franco; John M Starr; Kiang Liu; Luigi Ferrucci; Ozren Polasek; James F Wilson; Tiphaine Oudot-Mellakh; Harry Campbell; Pau Navarro; Stefania Bandinelli; Johan Eriksson; Dorret I Boomsma; Abbas Dehghan; Robert Clarke; Anders Hamsten; Eric Boerwinkle; J Wouter Jukema; Silvia Naitza; Paul M Ridker; Henry Völzke; Ian J Deary; Alexander P Reiner; David-Alexandre Trégouët; Christopher J O'Donnell; David P Strachan; Annette Peters; Nicholas L Smith Journal: PLoS One Date: 2014-12-31 Impact factor: 3.240
Authors: Mika Martiskainen; Niku Oksala; Tarja Pohjasvaara; Markku Kaste; Anni Oksala; Pekka J Karhunen; Timo Erkinjuntti Journal: BMC Neurol Date: 2014-06-22 Impact factor: 2.474
Authors: Ji-Feng Li; Yuan Lin; Yuan-Hua Yang; Hui-Li Gan; Yan Liang; Jie Liu; Su-Qiao Yang; Wei-Juan Zhang; Na Cui; Lan Zhao; Zhen-Guo Zhai; Jun Wang; Chen Wang Journal: PLoS One Date: 2013-07-22 Impact factor: 3.240